Filter
844
Filtered Results: 844
Text search:
NTD
Featured
Recommendations
69
New Publications
145
Language
Document type
No document type
258
Studies & Reports
218
Guidelines
86
Resource Platforms
83
Strategic & Response Plan
65
Fact sheets
32
Videos
25
Manuals
24
Infographics
17
Online Courses
13
Training Material
6
Brochures
6
Situation Updates
5
Dashboards/Maps
4
App
2
Countries / Regions
Global
197
Africa
23
Ethiopia
18
Kenya
17
Liberia
17
Latin America and the Carribbean
16
Uganda
16
Sierra Leone
14
Nepal
11
India
11
Malawi
10
Mozambique
10
Tanzania
9
West and Central Africa
9
East and Southern Africa
9
Bangladesh
9
Ghana
7
Middle East and North Africa
7
South Africa
7
Brazil
7
Zambia
7
Rwanda
6
Nigeria
6
Asia
6
South–East Asia Region
6
South Sudan
6
Colombia
4
Zimbabwe
4
Sudan
4
Chile
3
Cameroon
3
Senegal
3
Congo, Democratic Republic of
3
Southern Africa
3
Namibia
3
Botswana
3
Somalia
3
Syria
2
Iran
2
Afghanistan
2
Guinea
2
Jordan
2
Saudi Arabia
2
Western and Central Europe
2
Paraguay
2
Argentina
2
Lebanon
2
Angola
2
Iraq
2
Madagascar
2
Pakistan
2
Mexico
1
Ukraine
1
El Salvador
1
Togo
1
China
1
Albania
1
Morocco
1
Qatar
1
Mauritania
1
Philippines
1
Cambodia
1
Venezuela
1
Germany
1
Eastern Europe and Central Asia
1
North America
1
Uruguay
1
Tunisia
1
Côte d’Ivoire / Ivory Coast
1
Bolivia
1
Vietnam
1
Djibouti
1
Egypt
1
Yemen
1
Greece
1
Palestine
1
Georgia
1
Honduras
1
Chad
1
Libya
1
Indonesia
1
Eswatini/ Swaziland
1
Authors & Publishers
Publication Years
Category
Countries
195
Clinical Guidelines
131
Public Health
50
Key Resources
21
Capacity Building
11
Pharmacy & Technologies
11
Women & Child Health
7
Annual Report MEDBOX
1
Toolboxes
NTDs
442
Global Health Education
24
Planetary Health
22
Rapid Response
21
HIV
19
COVID-19
18
Zika
18
Caregiver
15
Disability
11
Pharmacy
7
Mental Health
5
Ebola
5
Health Financing Toolbox
4
NCDs
4
AMR
4
TB
3
Refugee
2
Cholera
2
Polio
2
Natural Hazards
1
Conflict
1
This document outlines the evaluation process that WHO undertakes to assess novel tools and strategies targeted at VBDs. Its aim is to articulate the linkage between the generation of evidence that demonstrates public health impact of novel interventions, and the development of policy recommendation...
The purpose of this TPP is to communicate the minimum and ideal characteristics desired to meet the need for discriminating low levels of risk for transmission, i.e. targeted prevalence thresholds in the surveyed areas. An in vitro diagnostic test is needed for the detection of analyte(s) specific t...
BMZ Papier 1
Gesundheit ist nicht nur Voraussetzung für ein selbstbestimmtes Leben, sondern auch essenziell für die gesellschaftliche und nachhaltige wirtschaftliche Entwicklung in unseren Partnerländern. Die gegenwärtige COVID-19 Pandemie zeigt, welche Gefahren von Infektionskrankheiten ausge...
Information for policy-makers and planners on conducting deworming as part of an integrated
school health program
The larval stage of the parasite Taenia solium can encyst in the central nervous system causing neurocysticercosis, which is the main cause of acquired epilepsy in the countries in which the parasite is endemic. Endemic areas are those with the presence (or likely presence) of the full life cycle of...
Clinical Microbiology and Infection Volume 21, Issue 5, May 2015, Pages 433-443;
The neglected zoonotic diseases (NZDs) have been all but eradicated in wealthier countries, but remain major causes of ill-health and mortality across Africa, Asia, and Latin America. This neglect is, in part, a conse...
In 2009, WHO’s Second International Conference on Buruli Ulcer Control and Research resolved to strengthen the capacity of national laboratories to confirm cases of the disease, but advised that “efforts are still needed to develop simple diagnostic tools usable in the field as well as disabilit...
Combined questionnaire Core
2nd edition. These guidelines include several notable changes from the first edition. For cutaneous leishmaniasis, ketoconazole has been removed from the list of treatment options; the number of Leishmania species for which there is strong evidence for the efficacy of miltefosine has increased from ...
This annual report highlights the work of the WHO from January to June 2021 ( December 2021). The activities featured herein are by no means exhausted but implemented with technical and financial support through WHO in Nigeria; facilitated by its presence at all levels of governance (national, state...
In 2013, WHO and the Foundation for Innovative New Diagnostics convened a meeting of Buruli ulcer experts in Geneva, Switzerland (9) at which two priority unmet needs in diagnosis were identified:
a diagnostic test for early detection of Buruli ulcer in symptomatic patients with sufficient positive...
Canadian Journal of Microbiology 25 June 2021 https://doi.org/10.1139/cjm-2020-0572
This Trachoma Action Planning – a planning guide – is published by the
International Coalition for Trachoma Control at the request of the
World Health Organization Alliance for the Global Elimination of Trachoma
by 2020.
A qualitative assessment of knowledge gaps about female genital schistosomiasis among communities living in Schistosoma haematobium endemic districts of Zanzibar and Northwestern Tanzania.
PloS Neglected Tropical Diseases September 30, 2021 https://doi.org/10.1371/journal.pntd.0009789
Schistosoma...
PLoS Neglected Tropical diseases August 16, 2021 https://doi.org/10.1371/journal.pntd.0009697
Chagas disease, also known as American trypanosomiasis, is a neglected tropical disease transmitted by triatomine insects, first identified in 1909. Chagas disease affects approximately 6–7 million peop...
Over 6 million people worldwide are infected with Trypanosoma cruzi, the protozoan that causes Chagas disease
(CD). T. cruzi is transmitted by triatomine insects, congenitally, through uncontrolled blood donations and organ transplants,
and via consumption of food or drink contaminated by triatomi...
In support of the London Declaration goals, PATH aims to catalyze engagement of the diagnostics industry and product development efforts. As part of this work, PATH conducted a diagnostic landscape analysis to identify gaps and evaluated current and nascent HAT diagnostics that may provide solutions...
Localized cutaneous leishmaniasis and its evolving forms (diffuse cutaneous leishmaniasis, mucosal leishmaniasis and cutaneous leishmaniasis recidivans), together with the sequela of visceral leishmaniasis (post-kala-azar dermal leishmaniasis), account for about one million cases of dermal leishmani...
Leishmaniasis is a climate-sensitive disease. Changes in temperature, rainfall, and humidity can have strong impacts on
the sandfly vector, altering their distribution and influencing their survival and population sizes. Increased temperatures shorten vector development time, reduce Leishmania para...
